- Home
- ACHV vs AMWL Comparison
ACHV vs AMWL Comparison
Compare ACHV & AMWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACHV
- AMWL
- Stock Information
- Founded
- ACHV N/A
- AMWL 2006
- Country
- ACHV United States
- AMWL United States
- Employees
- ACHV N/A
- AMWL N/A
- Industry
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- AMWL Retail: Computer Software & Peripheral Equipment
- Sector
- ACHV Health Care
- AMWL Technology
- Exchange
- ACHV Nasdaq
- AMWL Nasdaq
- Market Cap
- ACHV 131.3M
- AMWL 111.4M
- IPO Year
- ACHV N/A
- AMWL 2020
- Fundamental
- Price
- ACHV $3.08
- AMWL $6.63
- Analyst Decision
- ACHV Strong Buy
- AMWL Hold
- Analyst Count
- ACHV 2
- AMWL 7
- Target Price
- ACHV $16.00
- AMWL $9.17
- AVG Volume (30 Days)
- ACHV 1.6M
- AMWL 55.1K
- Earning Date
- ACHV 11-06-2025
- AMWL 10-29-2025
- Dividend Yield
- ACHV N/A
- AMWL N/A
- EPS Growth
- ACHV N/A
- AMWL N/A
- EPS
- ACHV N/A
- AMWL N/A
- Revenue
- ACHV N/A
- AMWL $269,783,000.00
- Revenue This Year
- ACHV N/A
- AMWL N/A
- Revenue Next Year
- ACHV N/A
- AMWL $3.38
- P/E Ratio
- ACHV N/A
- AMWL N/A
- Revenue Growth
- ACHV N/A
- AMWL 5.83
- 52 Week Low
- ACHV $1.84
- AMWL $6.10
- 52 Week High
- ACHV $5.31
- AMWL $12.95
- Technical
- Relative Strength Index (RSI)
- ACHV 56.04
- AMWL 41.05
- Support Level
- ACHV $2.68
- AMWL $6.46
- Resistance Level
- ACHV $3.30
- AMWL $7.01
- Average True Range (ATR)
- ACHV 0.25
- AMWL 0.25
- MACD
- ACHV 0.02
- AMWL 0.00
- Stochastic Oscillator
- ACHV 49.38
- AMWL 21.32
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
About AMWL American Well Corporation
American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others.